We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
FDA permits marketing of mobile medical application for substance use disorder.
- Abstract
Last month, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorder (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana, and stimulant SUDs. The application is not intended to be used to treat opioid dependence.
- Subjects
ALCOHOLISM treatment; SUBSTANCE abuse treatment; CANNABIS (Genus); COCAINE; GANGLIONIC stimulating agents; OUTPATIENT services in hospitals; TELEMEDICINE; UNITED States. Food &; Drug Administration; MOBILE apps
- Publication
Brown University Child & Adolescent Psychopharmacology Update, 2017, Vol 19, Issue 10, p8
- ISSN
1527-8395
- Publication type
Article
- DOI
10.1002/cpu.30251